CorVel Corporation (CRVL)
NASDAQ: CRVL
· Real-Time Price · USD
78.64
0.23 (0.29%)
At close: Sep 26, 2025, 3:59 PM
78.64
0.00%
After-hours: Sep 26, 2025, 04:20 PM EDT
CorVel Revenue Breakdown
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Network Solutions Services Revenue | 82.53M | 82.11M | 77.21M | 72.55M | 66.64M | 70.55M | 65.72M | 62.41M | 60.47M | 57.96M | 61.5M | 60.14M | 56.8M | 53.07M | 52.17M | 48.68M | 44.95M | 45.78M | 44.38M | 53.74M | 49.77M | 51.26M | 50.65M | 54.85M | 53.95M | 56.23M | 62.51M |
Network Solutions Services Revenue Growth | +0.50% | +6.35% | +6.42% | +8.87% | -5.54% | +7.35% | +5.29% | +3.22% | +4.33% | -5.76% | +2.26% | +5.88% | +7.01% | +1.73% | +7.17% | +8.30% | -1.80% | +3.15% | -17.42% | +7.98% | -2.91% | +1.20% | -7.66% | +1.67% | -4.05% | -10.04% | n/a |
Patient Management Services Revenue | 148.99M | 145.86M | 147.17M | 139.17M | 140.6M | 131.76M | 129.81M | 127.84M | 118.92M | 119.47M | 114.81M | 111.22M | 107.71M | 104.67M | 100.45M | 96.83M | 96.55M | 90.25M | 85.22M | 93.29M | 98.33M | 95.72M | 99.49M | 96.23M | 92.13M | 91.94M | 87.89M |
Patient Management Services Revenue Growth | +2.14% | -0.89% | +5.75% | -1.01% | +6.71% | +1.50% | +1.54% | +7.50% | -0.46% | +4.06% | +3.23% | +3.26% | +2.91% | +4.20% | +3.74% | +0.28% | +6.99% | +5.90% | -8.65% | -5.13% | +2.73% | -3.80% | +3.39% | +4.45% | +0.20% | +4.61% | n/a |
Operating Expense Breakdown
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 21.48M | 24.65M | 22.06M | 22.08M | 20.12M | 14.12M | 19.8M | 19.54M | 16.45M | 19.36M | 18.13M | 17.55M | 18.67M | 16.79M | 17.51M | 16.66M | 16.64M | 16.37M | 16.94M | 15.56M | 15.59M | 15.87M | 17M | 16.59M | 15.75M | 16.46M | 15.8M | 15.09M | 15.94M | 15.55M | 15.5M | 13.67M | 14.63M | 15M | 14.13M | 14.64M | 13.46M | 15.81M | 14.5M | 13.21M | 14.96M | 13.62M |
Selling, General, and Administrative Revenue Growth | -12.86% | +11.74% | -0.09% | +9.73% | +42.46% | -28.66% | +1.33% | +18.77% | -15.02% | +6.79% | +3.30% | -6.01% | +11.18% | -4.07% | +5.09% | +0.08% | +1.70% | -3.37% | +8.85% | -0.16% | -1.76% | -6.68% | +2.45% | +5.34% | -4.31% | +4.17% | +4.70% | -5.29% | +2.46% | +0.37% | +13.36% | -6.56% | -2.50% | +6.16% | -3.48% | +8.79% | -14.87% | +9.04% | +9.78% | -11.72% | +9.89% | n/a |
Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |